Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues

Documenti analoghi

• Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels
  di: Alessandro Sciahbasi, et al.
  Pubblicazione: (2024)
• Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis
  di: Tobias Koch, et al.
  Pubblicazione: (2024)
• Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies
  di: Monica Verdoia, et al.
  Pubblicazione: (2024)
• Paclitaxel‐coated versus sirolimus‐coated balloon angioplasty for coronary artery disease: A systematic review and meta‐analysis
  di: Doosup Shin, et al.
  Pubblicazione: (2024)
• Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
  di: Takashi Yanagiuchi, et al.
  Pubblicazione: (2024)